[1] Huang J, Liao Q, Mong HO, et al. Epidemiology of Recurrent Hand, Foot and Mouth Disease, China, 2008-2015. Emerg Infect Dis, 2018; 24, 432−42.
[2] Arena MP, Elmastour F, Sane F, et al. Inhibition of coxsackievirus B4 by Lactobacillus plantarum. Microbiol Res, 2018; 210, 59−64. doi:  10.1016/j.micres.2018.03.008
[3] Tian X, Zhang Y, Gu S, et al. New coxsackievirus B4 genotype circulating in Inner Mongolia Autonomous Region, China. PLoS One, 2014; 9, e90379. doi:  10.1371/journal.pone.0090379
[4] Xiao J, Wang J, Zhang Y, et al. Coxsackievirus B4: an underestimated pathogen associated with a hand, foot, and mouth disease outbreak. Arch Virol, 2021; 166, 2225−34. doi:  10.1007/s00705-021-05128-5
[5] Hu Y, Du J, Zhao R, et al. Complete genome sequence of a recombinant coxsackievirus B4 from a patient with a fatal case of hand, foot, and mouth disease in Guangxi, China. J Virol, 2012; 86, 10901−2. doi:  10.1128/JVI.01808-12
[6] Zhu Y, Pan Y, Chen J, et al. A Coxsackie B4 virus isolated in Yunnan in 2009 is a recombinant. Virus Genes, 2015; 50, 375−80. doi:  10.1007/s11262-015-1185-x
[7] Joffret ML, Polston PM, Razafindratsimandresy R, et al. Whole Genome Sequencing of Enteroviruses Species A to D by High-Throughput Sequencing: Application for Viral Mixtures. Front Microbiol, 2018; 9, 2339. doi:  10.3389/fmicb.2018.02339
[8] Anne G, Famara S, Magali S, et al. Specificity of the coxsackievirus B4 VP4 capsid protein investigated in silico. Discov Med, 2011; 12, 153−8.
[9] Ramsingh AI, Collins DN. A point mutation in the VP4 coding sequence of coxsackievirus B4 influences virulence. J Virol, 1995; 69, 7278−81. doi:  10.1128/jvi.69.11.7278-7281.1995
[10] Caggana M, Chan P, Ramsingh A. Identification of a single amino acid residue in the capsid protein VP1 of coxsackievirus B4 that determines the virulent phenotype. J Virol, 1993; 67, 4797−803. doi:  10.1128/jvi.67.8.4797-4803.1993
[11] Oberste MS, Maher K, Pallansch MA. Evidence for frequent recombination within species human enterovirus B based on complete genomic sequences of all thirty-seven serotypes. J Virol, 2004; 78, 855−67. doi:  10.1128/JVI.78.2.855-867.2004